Bogle Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bogle Investment Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-7,725	Closed	-$258K	–	410
2017 Q2	$258K	Sell	7,725 -231,567	-97%	-$6.91M	0.02%	276
2017 Q1	$6.93M	Buy	239,292 +57,426	+32%	+$1.42M	0.48%	82
2016 Q4	$4.06M	Sell	181,866 -91,428	-33%	-$1.79M	0.28%	115
2016 Q3	$5.08M	Buy	273,294 +125,827	+85%	+$2.37M	0.37%	96
2016 Q2	$2.4M	Buy	+147,467	New	+$2.17M	0.17%	162
2016 Q1	–	Sell	-139,955	Closed	-$1.63M	–	538
2015 Q4	$1.63M	Sell	139,955 -224,160	-62%	-$2.84M	0.12%	214
2015 Q3	$4.46M	Buy	+364,115	New	+$4.64M	0.32%	115
2014 Q4	–	Sell	-128,154	Closed	-$859K	–	481
2014 Q3	$859K	Sell	128,154 -141,894	-53%	-$995K	0.06%	260
2014 Q2	$1.94M	Sell	270,048 -112,189	-29%	-$893K	0.13%	192
2014 Q1	$3.86M	Sell	382,237 -90,435	-19%	-$832K	0.26%	123
2013 Q4	$3.75M	Sell	472,672 -15,100	-3%	-$141K	0.32%	112
2013 Q3	$4.83M	Buy	487,772 +73,634	+18%	+$580K	0.49%	78
2013 Q2	$2.44M	Buy	+414,138	New	+$1.39M	0.3%	119

Other funds holding BEAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bogle Investment Management's BEAT Position: Q3 2017 in Review

Bogle Investment Management sold out of BioTelemetry, Inc. (BEAT) in Q3 2017, closing a stake of 7,725 shares — an estimated $258K sold.

Bogle Investment Management first reported a position in BEAT in Q2 2013 and held it in 13 quarters. The position peaked at $6.93M in Q1 2017. 211 funds tracked by Wall St. Rank hold BEAT as of Q3 2017.

Bogle Investment Management reported no remaining BioTelemetry, Inc. position as of Q3 2017 after selling out during the quarter.
Bogle Investment Management sold 7,725 BioTelemetry, Inc. shares in Q3 2017, an estimated $258K.
Bogle Investment Management first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 13 quarters.
Bogle Investment Management's BioTelemetry, Inc. position peaked at $6.93M in Q1 2017.
211 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q3 2017.

Based on Bogle Investment Management's 13F filing for Q3 2017, filed 14 Nov 2017.